Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7737256 | 0.74 | — | — | |
| SCHEMBL29210939 | 0.70 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL2696185 | 0.70 | CYP3A4 (0.31) | ALDH1A1 | |
| SCHEMBL9939377 | 0.69 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL861711 | 0.69 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL12641823 | 0.68 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL29210943 | 0.67 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL3344254 | 0.66 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL1048910 | 0.66 | ALDH1A1 (0.42) | ALDH1A1 | |
| SCHEMBL1048909 | 0.66 | ALDH1A1 (0.42) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6794525-B2 | USING CHIRAL DIPHOSPHINES AS OPTICALLY ACTIVE LIGANDS FOR THE PREPARATION OF DIPHOSPHINO-METAL COMPLEXES | PPG-SIPSY (FR) | 2004-09-21 | — | — | US | disclosed |
| US-20030195369-A1 | Optically active chiral diphosphine ligands | PPG-SIPSY (FR) | 2003-10-16 | — | — | US | disclosed |
| EP-1305324-A1 | USE OF CHIRAL DIPHOSPHINES AS OPTICALLY ACTIVE LIGANDS | PPG-Sipsy (FR) | 2003-05-02 | — | — | EP | disclosed |
| WO-2002012253-A1 | USE OF CHIRAL DIPHOSPHINES AS OPTICALLY ACTIVE LIGANDS | PPG-SIPSY (FR) | 2002-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195369-A1 | Optically active chiral diphosphine ligands | NR4A1, GPR4, HTR4 | ALDH1A1 1484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.